GM21943
Fibroblast from Skin, Unspecified
Description:
MARFAN SYNDROME; MFS
FIBRILLIN 1; FBN1
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Biopsy Source
|
Unspecified
|
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Sample Source
|
Fibroblast from Skin, Unspecified
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
PDL at Freeze |
6.54 |
Passage Frozen |
8 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
FBN1 |
Chromosomal Location |
15q21.1 |
Allelic Variant 1 |
134797.0026; MARFAN SYNDROME |
Identified Mutation |
CYS1242TYR; In a patient with Marfan syndrome, Kainulainen et al. (1994) identified a G-to-A change at nucleotide 3725 of the FBN1 gene, resulting in a cys1242-to-tyr substitution.
|
Yin X, Wanga S, Fellows A, Barallobre-Barreiro J, Lu R, Davaapil H, Franken R, Fava M, Baig F, Skroblin P, Xing Q, Koolbergen DR, Groenink M, Zwinderman AH, Balm R, de Vries CJM, Mulder BJM, Viner R, Jahangiri M, Reinhardt DP, Sinha S, de Waard V, Mayr M, Glycoproteomic Analysis of the Aortic Extracellular Matrix in Marfan Patients Arteriosclerosis, thrombosis, and vascular biology:ATVBAHA118312175 2019 |
PubMed ID: 31315432 |
|
Schrijver I, Liu W, Brenn T, Furthmayr H, Francke U, Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes American journal of human genetics65:1007-20 1999 |
PubMed ID: 10486319 |
Passage Frozen |
8 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
3% |
Medium |
Eagles Minimum Essential Medium with Earle's salts:Dulbecco's modified MEM with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Supplement |
- |
|
|